Real humans read every request · typical reply in 2 hours · All 50 states. Standing weekly programs. Same-day dispatch in most major metros.
ICH guideline describing a model pharmaceutical quality system across the product lifecycle, including oversight of outsourced activities and purchased materials such as packaging and pallets.
Get a Price →ICH guideline describing a model pharmaceutical quality system across the product lifecycle, including oversight of outsourced activities and purchased materials such as packaging and pallets.
ICH Q10, Pharmaceutical Quality System, is a guideline from the International Council for Harmonisation that describes how a drug manufacturer can run an effective quality system from development through commercial manufacturing to product discontinuation. It builds on GMP and ISO quality concepts. Its core elements are process performance and product quality monitoring, corrective and preventive action (CAPA), change management and management review, supported by knowledge management and quality risk management under ICH Q9. FDA has published Q10 as guidance for industry.
Q10 says the manufacturer remains responsible for the quality of outsourced activities and purchased materials. That means assessing suppliers before use, defining responsibilities in agreements, monitoring performance and reviewing changes. Pallets are not named in the guideline, but companies apply this framework to every material and service that can affect product quality, which in practice can include pallets used in manufacturing and distribution.
The level of control should match the risk. A pallet used only for finished, sealed cartons in a warehouse is usually lower risk than one entering a manufacturing area, and the customer's risk assessment decides how much oversight is needed.
Q10 also expects management review and continual improvement, so a customer may come back with corrective actions after a complaint or deviation involving pallets. Responding with a documented root cause and fix is part of staying an approved supplier.
No. ICH Q10 is a harmonized guideline. Regulators in ICH member regions, including FDA, have adopted it as guidance, and inspectors use it as a reference for what a modern pharmaceutical quality system looks like. The binding requirements remain the GMP regulations of each jurisdiction, such as 21 CFR Parts 210 and 211 in the US. Following Q10 helps companies meet those requirements in a structured way.
ICH Q9 covers quality risk management: the methods for identifying, assessing, controlling and reviewing risks to product quality. ICH Q10 describes the overall quality system and names quality risk management as one of its key enablers. In practice, a company uses Q9 tools to decide, for example, how strictly to control a supplier, and Q10 elements such as change management and management review to carry out and monitor those decisions.